A Study of Andecaliximab in Participants With Fibrodysplasia Ossificans Progressiva (FOP)

NCT06508021 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

92

Enrollment

INDUSTRY

Sponsor class

Conditions

Fibrodysplasia Ossificans Progressiva

Interventions

DRUG: Andecaliximab
DRUG: Placebo
DRUG: Andecaliximab

Sponsor

Ashibio Inc